Unknown NA INTERVENTIONAL 2-arm NCT04454515

The Effect of Intraoperative Dexmedetomidine on Postoperative Morphine Requirements After Breast Cancer Surgery

The Effect of Intraoperative Dexmedetomidine on Postoperative Morphine Requirements and Oral Intake After Breast Cancer Surgery

Sponsor: National Taiwan University Hospital

Conditions Morphine Consumption

Interventions Dexmedetomidine placebo

Updated 8 times since 2020 Last updated: Jan 16, 2024 Started: Apr 20, 2021 Primary completion: Jul 1, 2024 Completion: Jul 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Morphine Consumption, this trial is ongoing. The trial is conducted by National Taiwan University Hospital and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Aug 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2024 — Jul 2024 [monthly]

Recruiting NA
Jun 2022 — Feb 2024 [monthly]

Recruiting NA

▶ Show 3 earlier versions

May 2022 — Jun 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — May 2022 [monthly]

Not Yet Recruiting NA
Aug 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan